ESC 365 - Comparative effectiveness of angiotensin ii receptor blockers versus angiotensin-converting enzyme inhibitors in acute myocardial infarction

ESC2025 Premium Access

Comparative effectiveness of angiotensin ii receptor blockers versus angiotensin-converting enzyme inhibitors in acute myocardial infarction

Session: New perspectives in cardiology (3) - Pharmacotherapy

Topic: Angiotensin-Renin-Bradykinin System

Speaker: Doctor P. Sun (Tianjin, CN)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Pengfei Sun

Tianjin Medical University General Hospital, Tianjin (China)

0 follower

10 more presentations in this session

Discussant - Pharmacotherapy

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Ph2 Trial of Pacibekitug SC Quarterly or Monthly in Patients with Elevated hs-CRP and Chronic Kidney Disease: TRANQUILITY 90-Day Results

Speaker: Professor D. Bhatt (New York, US)

SGLT2 inhibitors on the prevention of contrast-induced acute kidney injury in patients with type 2 diabetes after coronary revascularization: a systematic review and meta-analysis

Speaker: Doctor K. Dimitriadis (Athens, GR)

GLP-1 RAs reduce mortality and cardiovascular events across the spectrum of treated patients: a systematic review and meta-analysis

Speaker: Doctor M. Galli (Rome, IT)

Comparative effectiveness of GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors on cardiovascular outcomes: A comprehensive Bayesian network meta-analysis with intervention ranking

Speaker: Doctor M. Rahman (Flushing, US)

Access the full session

New perspectives in cardiology (3) - Pharmacotherapy

Speakers: Doctor P. Sun, Professor D. Bhatt, Doctor K. Dimitriadis, Doctor M. Galli, Doctor M. Rahman

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources